John Hodges

Professor John Hodges is Professor of Cognitive Neurology in the Brain and Mind Centre at the University of Sydney. He qualified in medicine from London University with honours in 1975 and earned his MD in 1988 after periods of psychiatric and neurological training in Southampton, Oxford, and San Diego. He undertook postgraduate neurology training in London. From 1997 to 2007, he served as the MRC Professor of Behavioural Neurology with joint appointments in the Department of Clinical Neurosciences at Addenbrooke’s Hospital and the MRC Cognition and Brain Sciences Unit in Cambridge, where he led a multidisciplinary research group. In 2007, he relocated to Sydney as an Australian Research Council Federation Fellow and Professor of Cognitive Neurology at Neuroscience Research Australia. In 2016, he joined the University of Sydney’s Brain and Mind Centre along with his team of researchers, PhD students, and staff, and now co-leads the Frontier research group, Australia’s first dedicated frontotemporal dementia research group.

Professor Hodges specializes in cognitive aspects of neurodegenerative disorders, with a primary focus on frontotemporal dementia. The Frontier team examines apathy in dementia, social cognition and memory changes, structural and functional brain progression, metabolic changes, severity rating scales, neuropathology, genetics, clinical and biological markers, cognition in motor neurone disease, and impacts on patients, carers, and families. Research integrates cognitive testing, neuroimaging, and interventions for support. He has published over 450 journal articles and five books, including Cognitive Assessment for Clinicians, Early Onset Dementia, and Frontotemporal Dementia Syndromes. Major publications include Classification of primary progressive aphasia and its variants (2011) and Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia (2011). He developed the Addenbrooke’s Cognitive Examination Revised (2006) and its successor ACE-III (2013), widely used for dementia screening. Awards include the Bengt Winblad Lifetime Achievement Award in Alzheimer’s Disease Research (2015), and he ranks among Nature’s top 400 most-cited biomedical scientists.

Professional Email: john.hodges@sydney.edu.au